Apollomics, Inc. (APLM)
19.51
-0.39
(-1.96%)
USD |
NASDAQ |
Mar 16, 16:00
Apollomics Market Cap : 41.82M for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.587B |
| Agenus, Inc. | 132.28M |
| Alnylam Pharmaceuticals, Inc. | 43.06B |
| Savara, Inc. | 1.047B |
| Arrowhead Pharmaceuticals, Inc. | 8.029B |
Market Cap Related Metrics
| PS Ratio | 2.532 |
| Price | 19.51 |
| Earnings Yield | -144.9% |